Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study-Reference-Cited by-同舟云学术

Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study

Published:2018 Issue:2 Volume:2 Page:
ISSN:2514-1775
Container-title:Rheumatology Advances in Practice
language:en
Short-container-title:

Author:

Clunie Gavin¹,McInnes Iain B²,Barkham Nick³,Marzo-Ortega Helena⁴⁵,Patel Yusuf⁶,Gough Andrew⁷,Packham Jon⁸,Kyle Stuart⁹,Kirkham Bruce¹⁰,Sheeran Tom¹¹,Coope Helen¹²,Bishop-Bailey Anna¹³,McHugh Neil¹⁴

Affiliation:

1. Rheumatology, Addenbrookes Hospital, Cambridge

2. Rheumatology, Glasgow Royal Infirmary, Glasgow

3. Rheumatology, New Cross Hospital, Wolverhampton

4. NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust Leeds, Leeds

5. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds

6. Rheumatology, Hull Royal Infirmary, Hull

7. Rheumatology, Harrogate District Hospital, Harrogate

8. Rheumatology, Haywood Hospital, Stoke-on-Trent

9. Rheumatology, North Devon Hospital, Barnstaple

10. Rheumatology, Guy’s and St Thomas’ NHS Foundation Trust, London

11. Rheumatology, Cannock Chase Hospital, Cannock

12. Immunology & Dermatology, Novartis Pharmaceuticals UK Limited, Frimley

13. Real World Evidence, pH Associates, Marlow

14. Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK

Funder

Novartis Pharmaceuticals UK Ltd

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

http://academic.oup.com/rheumap/article-pdf/2/2/rky042/28866429/rky042.pdf

Reference42 articles.

1. Psoriatic arthritis: current therapy and future approaches;Huynh;Rheumatology,2015

2. The epidemiology psoriatic arthritis;Ogdie;Rheum Dis Clin North Am,2015

3. Emerging biomarkers in psoriatic arthritis;Yeon Paek;IUBMB Life,2015

4. Advances in the management of psoriatic arthritis;Olivieri;Nat Rev Rheumatol,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52‐Week Results From Two Phase 3 Studies;ACR Open Rheumatology;2024-07-30

2. Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis;Arthritis & Rheumatology;2024-03-04

3. Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care;The Journal of Rheumatology;2024-01-15

4. Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response;Rheumatology Advances in Practice;2023-12-09

5. Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review;Modern Rheumatology;2023-04-06